Reply:

References

1. 1.↵
   2. Rozenfeld MN,
   3. Ansari SA,
   4. Shaibani A, et al

   . Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms? AJNR Am J Neuroradiol 2014;35:3–9 doi:10.3174/ajnr.A3437 pmid:23292526

   Abstract/FREE Full Text
2. 2.↵
   2. de la Monte SM,
   3. Moore GW,
   4. Monk MA, et al

   . Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 1985;78(6 pt 1):957–64 doi:10.1016/0002-9343(85)90218-9 pmid:4014270

   CrossRefPubMed
3. 3.↵
   2. Schievink WI,
   3. Torres VE,
   4. Piepgras DG, et al

   . Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992;3:88–95 pmid:1391712

   Abstract
4. 4.↵
   2. Lozano AM,
   3. Leblanc R

   . Cerebral aneurysms and polycystic kidney disease: a critical review. Can J Neurol Sci 1992;19:222–27 pmid:1623450

   PubMedWeb of Science
5. 5.↵
   2. Chapman AB,
   3. Johnson AM,
   4. Gabow PA

   . Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis 1993;22:526–31 doi:10.1016/S0272-6386(12)80924-3 pmid:8213791

   CrossRefPubMed
6. 6.↵
   2. Etminan N,
   3. Brown RD Jr.,
   4. Beseoglu K, et al

   . The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology 2015;85:881–89 doi:10.1212/WNL.0000000000001891 pmid:26276380

   CrossRefPubMed
7. 7.↵
   2. Greving JP,
   3. Wermer MJ,
   4. Brown RD Jr., et al

   . Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014;13:59–66 doi:10.1016/S1474-4422(13)70263-1 pmid:24290159

   CrossRefPubMed